about
Neutrophil Extracellular Traps in Pulmonary Diseases: Too Much of a Good Thing?Cannabinoid CB1 receptor overactivity contributes to the pathogenesis of idiopathic pulmonary fibrosis.Lung microbiome and host immune tone in subjects with idiopathic pulmonary fibrosis treated with inhaled interferon-γ.Skewed Lung CCR4 to CCR6 CD4+ T Cell Ratio in Idiopathic Pulmonary Fibrosis Is Associated with Pulmonary Function.Low-dose cadmium exposure induces peribronchiolar fibrosis through site-specific phosphorylation of vimentin.XIST/miR-139 axis regulates bleomycin (BLM)-induced extracellular matrix (ECM) and pulmonary fibrosis through β-catenin.Transforming growth factor-β plays divergent roles in modulating vascular remodeling, inflammation, and pulmonary fibrosis in a murine model of scleroderma.Essential involvement of the CX3CL1-CX3CR1 axis in bleomycin-induced pulmonary fibrosis via regulation of fibrocyte and M2 macrophage migration.Early Detection of Urinary Proteome Biomarkers for Effective Early Treatment of Pulmonary Fibrosis in a Rat Model.Metabolic characterization and RNA profiling reveal glycolytic dependence of profibrotic phenotype of alveolar macrophages in lung fibrosis.The Role of miR-497/EIF3A Axis in TGFβ1-Induced Epithelial-Mesenchymal Transition and Extracellular Matrix in Rat Alveolar Epithelial Cells and Pulmonary Fibroblasts.Innate Immunity of the Lung: From Basic Mechanisms to Translational Medicine.Activation of the Absent in Melanoma 2 Inflammasome in Peripheral Blood Mononuclear Cells From Idiopathic Pulmonary Fibrosis Patients Leads to the Release of Pro-Fibrotic Mediators.The diversity of myeloid immune cells shaping wound repair and fibrosis in the lung.S100a4 Is Secreted by Alternatively Activated Alveolar Macrophages and Promotes Activation of Lung Fibroblasts in Pulmonary Fibrosis.Resolution of bleomycin-induced murine pulmonary fibrosis via a splenic lymphocyte subpopulation.Involvement of Hookworm Co-Infection in the Pathogenesis and Progression of Podoconiosis: Possible Immunological MechanismTranslational Medicine in Pulmonary-Renal Crosstalk: Therapeutic Targeting of p-Cresyl Sulfate Triggered Nonspecific ROS and Chemoattractants in Dyspneic Patients with Uremic Lung Injury
P2860
Q26738321-5F366B3A-34D3-4EAC-897B-D649F4688411Q33579016-38F9D37B-BDA9-4B3F-801C-86C240571588Q33897430-FBBC994F-7BDE-457C-9D50-A1C5E9D80440Q37430348-92E2D5A3-C4FE-4597-8E74-67C3AE5C6398Q38816027-F1CDD238-4A6F-4758-8E82-B25C1CA42C74Q42371533-A69E712F-C55A-48C5-B296-859120DB6D2BQ46301833-76151AAB-9F8D-49C6-BCE7-533B1241F1CBQ47141962-DB6FE13A-7088-4CC3-A39C-B72CCABFDE32Q47448022-4EF81356-3795-4547-8592-26BCAD8539CDQ47804954-D839452D-408B-43ED-A031-AAC2E31FD0B5Q48098791-017C9431-8D57-4BD9-8EF7-AA1A26467C80Q50034841-6DC6AE11-98EB-42BE-94AC-90D1AEE3AB02Q52576092-6BCC1999-CEBE-4D51-B2D3-B255056945BFQ55046775-9BAF40CA-7730-4CEB-BD95-7D56A96B5D23Q55164785-2B41B5DF-B642-462D-BA55-2869D4959314Q55271396-5A59085D-5BDA-4E59-AB59-7A5306D0908DQ57147435-3F9CF957-8B8C-43D2-AF5D-23AC8DEEF95CQ58757048-99844FFB-2BED-451C-A69D-B21ADE131AE1
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Immune Mechanisms in Pulmonary Fibrosis.
@en
type
label
Immune Mechanisms in Pulmonary Fibrosis.
@en
prefLabel
Immune Mechanisms in Pulmonary Fibrosis.
@en
P2093
P2860
P356
P1476
Immune Mechanisms in Pulmonary Fibrosis.
@en
P2093
Dominik Hartl
Isis E Fernandez
Oliver Eickelberg
Saeed Kolahian
P2860
P304
P356
10.1165/RCMB.2016-0121TR
P577
2016-05-05T00:00:00Z